- Home
- BDSX vs XGN Comparison
BDSX vs XGN Comparison
Compare BDSX & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- XGN
- Stock Information
- Founded
- BDSX 2005
- XGN 2002
- Country
- BDSX United States
- XGN United States
- Employees
- BDSX N/A
- XGN N/A
- Industry
- BDSX Precision Instruments
- XGN Medical Specialities
- Sector
- BDSX Health Care
- XGN Health Care
- Exchange
- BDSX Nasdaq
- XGN Nasdaq
- Market Cap
- BDSX 115.4M
- XGN 138.3M
- IPO Year
- BDSX 2020
- XGN 2019
- Fundamental
- Price
- BDSX $0.45
- XGN $7.27
- Analyst Decision
- BDSX Strong Buy
- XGN Strong Buy
- Analyst Count
- BDSX 5
- XGN 3
- Target Price
- BDSX $1.75
- XGN $9.00
- AVG Volume (30 Days)
- BDSX 1.1M
- XGN 272.4K
- Earning Date
- BDSX 08-07-2025
- XGN 07-29-2025
- Dividend Yield
- BDSX N/A
- XGN N/A
- EPS Growth
- BDSX N/A
- XGN N/A
- EPS
- BDSX N/A
- XGN N/A
- Revenue
- BDSX $74,463,000.00
- XGN $56,724,000.00
- Revenue This Year
- BDSX $17.29
- XGN $18.92
- Revenue Next Year
- BDSX $29.33
- XGN $14.78
- P/E Ratio
- BDSX N/A
- XGN N/A
- Revenue Growth
- BDSX 35.76
- XGN 1.78
- 52 Week Low
- BDSX $0.17
- XGN $1.78
- 52 Week High
- BDSX $2.04
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- BDSX 75.72
- XGN 56.94
- Support Level
- BDSX $0.29
- XGN $6.81
- Resistance Level
- BDSX $0.44
- XGN $7.50
- Average True Range (ATR)
- BDSX 0.03
- XGN 0.33
- MACD
- BDSX 0.02
- XGN 0.02
- Stochastic Oscillator
- BDSX 98.04
- XGN 75.27
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.